Bicycle Therapeutics: chief prod & supply chain off Ferguson sold 1,814 shares

What happened The Form 4 reports that Hannay Michael Charles Ferguson, chief prod & supply chain off, sold a total of 1,814 shares. On Oct 2, 2026 he sold 1,572 shares at a reported weighted average price of $3.47 for $5,455. On Oct 5, 2026 he sold 242 shares at a reported weighted average price of $3.57 for $864.

Key details

• Transaction dates and prices: Oct 2, 2026 — 1,572 shares at a weighted average $3.47 (range $3.41 to $3.525) ; Oct 5, 2026 — 242 shares at a weighted average $3.57 (range $3.56 to $3.57).
• Total proceeds reported: $6,319.
• Shares owned after the transaction: not reported in the provided filing excerpt.
• Footnotes: F1 indicates the Oct 2 sale represents shares sold to cover statutory tax withholding on RSU vesting (a "sell to cover" required by the award agreement). F2 and F3 note the prices are weighted averages across the stated ranges and that the reporting person will provide details on request.
• Filing timing: the Form 4 was filed Oct 6, 2026 (reporting period Oct 2, 2026).

Why it may matter

• The filing shows these sales were sell-to-cover transactions tied to RSU vesting, not necessarily discretionary open-market sales.
• The filing does not show why the insider traded or why the company acted.